[Over-expression of DLL4/Notch1 ligand inhibits proliferation of K562 cells]

Hong-Bing Rui1, Han-Hua Zhang1, Li-Fang Shi1

  • 1Department of Hematology,The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, Fujian Province, China.

Insights

Over-expressing DLL4 in K562 leukemia cells activates the Notch1 pathway, increasing Rb, YY1, and C-MYC. This inhibits cell proliferation and promotes apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Leukemia cell growth is a critical area of research.
  • The Notch signaling pathway plays a role in cell development and disease.
  • DLL4 is a ligand in the Notch signaling pathway.

Purpose of the Study:

  • To investigate the effect of DLL4/Notch1 ligand on K562 leukemia cell growth.
  • To elucidate the underlying mechanisms of DLL4's action in leukemia cells.

Main Methods:

  • K562 cells were transfected with a pBudCE4.1-DLL4 plasmid.
  • RT-PCR and Western blot were used to assess gene and protein expression (DLL4, Notch1-ICD, Hes1, Rb, YY1, C-MYC).
  • Cell proliferation and apoptosis were evaluated using Cell Counting Kit-8 and flow cytometry.

Main Results:

  • DLL4 transfection successfully activated the Notch1 signaling pathway, evidenced by increased DLL4, Notch1-ICD, and Hes1 expression.
  • Expression of Rb, YY1, and C-MYC proteins significantly increased in DLL4-transfected cells.
  • DLL4 overexpression inhibited K562 cell proliferation, enhanced apoptosis, and altered cell cycle distribution (increased G1, decreased S phase).

Conclusions:

  • DLL4 overexpression in K562 cells activates the Notch1 pathway.
  • This activation leads to increased Rb, YY1, and C-MYC expression.
  • DLL4 induces apoptosis and reduces proliferation in K562 leukemia cells.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.7K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K